Value of window technique in diagnosis of the ground glass opacities in patients with non-small cell pulmonary cancer

Yao,Gang

doi:10.3892/ol.2016.5133

Value of window technique in diagnosis of the ground glass opacities in patients with non-small cell pulmonary cancer

Authors:
- Gang Yao
View Affiliations

Affiliations: Department of Radiology, Zaozhuang Municipal Hospital, Zaozhuang, Shandong 277100, P.R. China
Published online on: September 14, 2016 https://doi.org/10.3892/ol.2016.5133
Pages: 3933-3935
Copyright: © Yao . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the value of window technique in qualitative diagnosis of the ground glass opacities (GGO) in patients with non-small cell pulmonary cancer. A total of 124 clinically suspected pulmonary cancer patients were analyzed retrospectively. The lesions were affirmed by puncture biopsy, and were GGO on pulmonary window while were invisible on mediastinal window. Sixty-four multi-detector spiral computed tomography with the window width and window level of 1,500 Hounsfield units (HU) and -450 HU on pulmonary window, while the window width and window level of 400 and 40 HU on mediastinal window, was used in the study. The window adjustment technique was used to analyze the window width and window level of lesion on pulmonary window and mediastinal window, for searching invisible threshold on 3-megapixel medical displays. The diagnostic accuracy and the cut-off value were compared on receiver operating characteristic (ROC) curve. The results showed that the window width and window level on pulmonary window and mediastinal window of malignant lesions were significantly less than those of benign ones (P<0.05). The cut-off value on pulmonary window was the window width and window level of 1,300 and -220 HU, the area under the ROC was 0.830 [sensitivity was 72.5%, specificity was 84.3%; 95% confidence interval (CI), 0.712-0.945]. The cut-off value on mediastinal window was the window width and window level of 360 and 30 HU, and the area under the ROC was 0.623 (was 62.0%, specificity was 55.7%; 95% CI, 0.541-0.745). In conclusion, the window technique has high sensitivity and accuracy in qualitative diagnosis of the GGO.

View Figures

View References

1	Min JH, Lee HY, Lee KS, Han J, Park K, Ahn MJ and Lee SJ: Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer. 69:123–126. 2010. View Article : Google Scholar : PubMed/NCBI
2	Pedersen JH, Saghir Z, Wille MM, Thomsen LH, Skov BG and Ashraf H: Ground-glass opacity lung nodules in the era of lung cancer ct screening: radiology, pathology, and clinical management. Oncology (Williston Park). 30:266–274. 2016.PubMed/NCBI
3	Saji H, Matsubayashi J, Akata S, Shimada Y, Kato Y, Kudo Y, Nagao T, Park J, Kakihana M, Kajiwara N, et al: Correlation between whole tumor size and solid component size on high-resolution computed tomography in the prediction of the degree of pathologic malignancy and the prognostic outcome in primary lung adenocarcinoma. Acta Radiol. 56:1187–1195. 2015. View Article : Google Scholar : PubMed/NCBI
4	Lee HY and Lee KS: Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging. 26:106–118. 2011. View Article : Google Scholar : PubMed/NCBI
5	Murakawa T, Konoeda C, Ito T, Inoue Y, Sano A, Nagayama K and Nakajima J: The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Eur J Cardiothorac Surg. 43:925–932. 2013. View Article : Google Scholar : PubMed/NCBI
6	Liu B, Mi RH, Wei XD, Chen L, Ai H, Yuan FF, Yin QS and Song YP: Clinical analysis of grand glass opacity on CT as the first change of lung infection accompanied by hematologic malignancies. Zhonghua Yi Xue Za Zhi. 96:163–166. 2016.(In Chinese). PubMed/NCBI
7	Nam KB, Kim TJ, Park JS, Chung MJ and Lee KW: Long-term follow-up results from PET/CT surveillance after surgical resection of lung adenocarcinoma manifesting as ground-glass opacity. Medicine (Baltimore). 95:e26342016. View Article : Google Scholar : PubMed/NCBI
8	Lee HN, Kim MY, Koo HJ, Kim SS, Yoon DH, Lee JC and Song JW: and Thin-Section CT: Thin-section ct characteristics and longitudinal CT follow-up of chemotherapy induced interstitial pneumonitis: a retrospective cohort study. Medicine (Baltimore). 95:e24602016. View Article : Google Scholar : PubMed/NCBI
9	Cha MJ, Lee KS, Kim HS, Lee SW, Jeong CJ, Kim EY and Lee HY: Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules. Expert Rev Respir Med. 10:261–278. 2016. View Article : Google Scholar : PubMed/NCBI
10	Chen CY, Chen CH, Shen TC, Cheng WC, Hsu CN, Liao CH, Chen CY, Hsia TC, Liao WC, Tu CY, et al: Lung cancer screening with low-dose computed tomography: experiences from a tertiary hospital in Taiwan. J Formos Med Assoc. 115:163–170. 2016. View Article : Google Scholar : PubMed/NCBI
11	Jiang G and Xie D: Early-stage lung cancer manifested as ground-glass opacity. Zhonghua Wai Ke Za Zhi. 53:790–793. 2015.(In Chinese). PubMed/NCBI
12	Bak SH, Lee HY, Kim JH, Um SW, Kwon OJ, Han J, Kim HK, Kim J and Lee KS: Quantitative CT scanning analysis of pure ground-glass opacity nodules predicts further CT scanning change. Chest. 149:180–191. 2016. View Article : Google Scholar : PubMed/NCBI
13	Ichikawa K, Kobayashi T, Sagawa M, Katagiri A, Uno Y, Nishioka R and Matsuyama J: A phantom study investigating the relationship between ground-glass opacity visibility and physical detectability index in low-dose chest computed tomography. J Appl Clin Med Phys. 16:50012015.PubMed/NCBI
14	Ikehara M, Saito H, Yamada K, Oshita F, Noda K, Nakayama H, Masui K, Kameda Y, Komase Y and Miyazawa T: Prognosis of small adenocarcinoma of the lung based on thin-section computed tomography and pathological preparations. J Comput Assist Tomogr. 32:426–431. 2008. View Article : Google Scholar : PubMed/NCBI
15	Honda T, Kondo T, Murakami S, Saito H, Oshita F, Ito H, Tsuboi M, Nakayama H, Yokose T, Kameda Y, et al: Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification. Clin Radiol. 68:e21–e26. 2013. View Article : Google Scholar : PubMed/NCBI
16	Yang F, Chen H, Xiang J, Zhang Y, Zhou J, Hu H, Zhang J and Luo X: Relationship between tumor size and disease stage in non-small cell lung cancer. BMC Cancer. 10:4742010. View Article : Google Scholar : PubMed/NCBI
17	Patz EF Jr, Rossi S, Harpole DH Jr, Herndon JE and Goodman PC: Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 117:1568–1571. 2000. View Article : Google Scholar : PubMed/NCBI